Exicure Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Exicure Inc 's ROA in the second quarter of 2026?
Exicure Inc recorded a cumulative net loss of $-8 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -61.98%.

However, within the Healthcare sector 627 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4074, from total ROA ranking in the first quarter of 2026 at 4256.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-39.18 %	-38.32 %	-6.74 %	171.03 %	354.92 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-8	-10	-5	-9	-8
Return On Assets (TTM)	-61.98 %	-64.37 %	-28.79 %	-52.93 %	-52.46 %
XCUR's Total Ranking	# 4074	# 4256	# 4046	# 4059	# 4034
Total Assets (TTM) in million	11	13	14	15	19
Seq. Total Assets Change	-10.65 %	-9.16 %	-8.03 %	-18.52 %	-9.39 %
Seq. Net Income Change	-	-	-	-	-

XCUR's 5 Years Annual ROA >> Back to XCUR Management Effectiveness >> Compare XCUR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 282
Sector	# 628
Overall	# 4015

Return On Assets Statistics
High	Average	Low
15.27 %	-59.39 %	-138.44 %
(Sep 30 2023)		(Jun 30 2022)

News about Exicure Inc Return on Assets ROA

“Exicure’s Nasdaq Nexus Compliance Challenges and the Path to Recovery in Biotech,

: In the fast-paced world of pharmaceutical innovation, maintaining a robust presence on the financial markets is crucial. Exicure, Inc. a biotechnology company pioneering the development of therapies based on its proprietary spherical nucleic acid (SNA) technology, has recently found itself under the scrutiny of Nasdaq. This article interprets Exicure s recent notices from the Nasdaq Hearings Panel and the Listing Qualifications Department, underscoring the implications for the company and its stakeholders. Exicure, Inc. recognized for its groundbreaking work in RNA-based therapies, recently encountered challenges regarding its continued listing on the Nasdaq Capital Market. On September 17, 2024, the company received a vital extension from the Nasdaq Hearings Panel. This development, while providing a temporary reprieve from delisting, indicates considerable scrutiny over its compliance with essential regulatory requirements.

Financial Statements
Exicure Inc 's Assets	$ 11 million	XCUR's Balance sheet
Exicure Inc 's Income	$ -1 million	Quarterly XCUR's Income Statement
XCUR's Income by Division		See XCUR's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-6.74 %	196.49 %	-69.37 %	-74.44 %	-35.42 %
Total Assets in million	14	15	5	17	65
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-5	-10	-17	-3	-64
Annual Return On Assets	-35.23 %	-64.43 %	-333.08 %	-15.57 %	-98.82 %

XCUR's 5 Years Annual ROA >> Back to XCUR Management Effectiveness >> Compare XCUR ROA to its Competitors

More Return On Assets Ratios
XCUR's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XCUR's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XCUR's Competitors
Subscribers only: Roa for Exicure Inc 's Suppliers
Subscribers only: Return On Assets for XCUR's Customers

You may also want to know
XCUR's Roi	XCUR's Inventory Turnover Ratio	XCUR's Growth Rates	XCUR's Dividend Comparisons
	XCUR's Profitability Ratios	XCUR's Asset Turnover Ratio	XCUR's Dividend Growth
XCUR's Roe	XCUR's Valuation Ratios	XCUR's Financial Strength Ratios	XCUR's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:24:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.